Testing THRIVE 365 for Black Sexual Minority Men (On The Daily) (OTD)

Rutgers The State University of New Jersey

Status: Completed

Conditions: Depressive Symptoms; Anxiety Symptoms; Medication Adherence; Emotion Regulation

Treatments: Behavioral: iTHRIVE 365

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05376397

K01MH118091 (U.S. NIH Grant/Contract)

Pro2021001082

Details and patient eligibility

About

The primary goal of this study is to test a minority stress model of psychological health outcomes for Black sexual minority men (BSMM) while using and not using a novel intervention named THRIVE 365. THRIVE 365 combines mHealth and institutional support elements to provide four areas of support for BSMM: 1) Promote HIV and psychological health knowledge and motivation; 2) Foster a sense of community and positive social connections among BSMM; 3) Connect clients to BSMM-affirming healthcare, including HIV treatment and mental healthcare; 4) Provide resources for housing, transportation, and other economic empowerment. To examine the effects of the intervention, we will utilize a 14-day daily diary study to capture daily intervention engagement, HIV and psychological health outcomes, coping, and experiences of racial and sexual minority stressors. We will first examine main associations between intervention engagement and HIV (antiretroviral treatment use) and psychological health (depressive symptoms, anxiety symptoms, emotion regulation difficulties outcomes) outcomes, then consider how intervention engagement affects coping and attenuates the impacts of racial and sexual minority stressors during the 14 day period.

Enrollment: 34 patients

Sex: Male

Ages: 16+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 16 years old or older ;
• Identifying as masculine
• Identifying as Black/African American
• Reporting being attracted to and/or sexually active with men;
• Able to complete all procedures in English.
• Mobile access to the internet in order to complete the once-daily survey procedures.

Exclusion criteria

• evidence of unstable, unmanaged, or serious psychiatric symptoms that could be made worse by participation;
• evidence of gross cognitive impairment that would interfere with successful completion of study procedures.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

34 participants in 1 patient group

iTHRIVE 365

Experimental group

Treatment:

Behavioral: iTHRIVE 365